alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Fourth Court of Appeals

San Antonio, Texas

July 17, 2015

No. 04-15-00307-CV

AUTOZONE, INC. and Autozoners L.L.C.,

Appellants

v.

Mario FLORES,

Appellee

From the 229th Judicial District Court, Starr County, Texas

Trial Court No. DC-15-6

Honorable Ana Lisa Garza, Judge Presiding

ORDER

Appellee’s brief in this accelerated appeal was July 13, 2015. Neither the brief nor a 

motion for extension of time has been filed.

We order appellee to file his brief by July 27, 2015. If the brief is not filed by the date 

ordered, we will order the case submitted without an appellee’s brief.

_________________________________

Luz Elena D. Chapa, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 17th day of July, 2015.

___________________________________

Keith E. Hottle

Clerk of Court
**EXHIBIT 23.1**

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

We consent to the incorporation by reference in the registration statement on Form S-8 (No. 333-40752) previously filed by Multicell Technologies, Inc of our report dated February 27, 2006, which contains anexplanatory paragraph relating to the Company’s ability to continue as a going concern, on our audit of the consolidated financial statements of Multicell Technologies, Inc. and Subsidiaries as of November 30, 2005 and 2004 (as restated)and for the years then ended, which report is included in this Annual Report on Form 10-KSB for the year ended November 30, 2005. 

/s/ J. H. Cohn LLP 

New York, NY 

February 27, 2006
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Affinion Group, Inc. (the Company) on Form 10-Q for the
quarter ended June 30, 2008, as filed with the Securities and Exchange Commission on the date hereof (the Form 10-Q), I, Nathaniel J. Lipman, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of
the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(i) the Form 10-Q fully complies with the requirements of
Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

(ii) the information contained in the Form 10-Q
fairly presents, in all material respects, the financial condition and result of operations of the Company.

Dated: July 31, 2008



|                                     
|-------------------------------------
|/s/ Nathaniel J. Lipman              
|Nathaniel J. Lipman                  
|President and Chief Executive Officer
1

In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS

No. 14-652V

Filed: June 19, 2015

* * * * * * * * * * * * * * * * * * * * * * * * * UNPUBLISHED

ASHLEY M. PIETRO, *

* Special Master Hamilton-Fieldman

Petitioner, *

v. * Attorneys’ Fees and Costs; Reasonable 

* Amount Requested to which Respondent 

SECRETARY OF HEALTH * Does Not Object.

AND HUMAN SERVICES, * 

* 

Respondent. * 

* * * * * * * * * * * * * * * * * * * * * * * * * 

Carol L. Gallagher, Carol L. Gallagher, Esquire, LLC, Linwood, NJ, for Petitioner.

Debra A. Begley, United States Department of Justice, Washington, DC, for Respondent.

DECISION1

On July 24, 2014, Ashley M. Pietro (“Petitioner”) filed a petition for compensation under 

the National Childhood Vaccine Injury Act of 1986, 42 U.S.C. §§ 300aa-1 et seq. (2006) 

(“Vaccine Act”). Petitioner alleged that the administration of a Human Papillomavirus vaccine 

(“HPV”), more specifically, a Gardasil vaccine, on August 16, 2011 caused her to suffer from 

Rheumatoid Arthritis. Petition (“Pet.”) at 1. On May 14, 2015, the undersigned issued a 

decision dismissing the case for insufficient proof. 

On June 19, 2015, Respondent filed a Stipulation of Facts Concerning Final Attorneys’ 

Fees and Costs. Pursuant to their Stipulation, the parties have agreed to an award of $18,969.50

in attorneys’ fees and costs. In accordance with General Order Number 9, Petitioner represents 

that she has not incurred any costs in pursuit of his claim. 

The undersigned finds that this petition was brought in good faith and that there existed a 

reasonable basis for the claim. Therefore, an award for fees and costs is appropriate, pursuant to 

42 U.S.C. § 300aa-15(b) and (e)(1). Further, the proposed amount seems reasonable and 

appropriate. Accordingly, the undersigned hereby awards the amount of $18,969.50, in the 

 

1 The undersigned intends to post this unpublished decision on the United States Court of Federal 

Claims’ website, in accordance with the E-Government Act of 2002, Pub. L. No. 107 347, § 205, 116 

Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). As provided by Vaccine Rule 

18(b), each party has 14 days within which to file a motion for redaction “of any information furnished by 

that party (1) that is trade secret or commercial or financial information and is privileged or confidential,

or (2) that are medical files and similar files the disclosure of which would constitute a clearly 

unwarranted invasion of privacy.” In the absence of such motion, the entire decision will be available to 

the public. Id. 
2

form of a check made payable jointly to Petitioner and Petitioner’s counsel, Carol L. 

Gallagher, Esq. 

In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of 

the court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ 

stipulation.2

IT IS SO ORDERED.

/s/ Lisa D. Hamilton-Fieldman 

Lisa D. Hamilton-Fieldman

Special Master

 

2 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of 

notice renouncing the right to seek review.
CHIEF JUSTICE

 CAROLYN WRIGHT

JUSTICES

 DAVID L. BRIDGES

 MOLLY FRANCIS

 DOUGLAS S. LANG

 ELIZABETH LANG-MIERS

 ROBERT M. FILLMORE

 LANA MYERS

 DAVID EVANS

 DAVID LEWIS

 ADA BROWN

 CRAIG STODDART

 BILL WHITEHILL

 DAVID J. SCHENCK

Court of Appeals

Fifth District of Texas at Dallas

600 COMMERCE STREET, SUITE 200

DALLAS, TEXAS 75202

(214) 712-3400

LISA MATZ

CLERK OF THE COURT

(214) 712-3450

lisa.matz@5th.txcourts.gov

GAYLE HUMPA

BUSINESS ADMINISTRATOR

(214) 712-3434

gayle.humpa@5th.txcourts.gov

FACSIMILE

(214) 745-1083

INTERNET

HTTP://5TH.TXCOURTS.GOV

July 23, 2015

Chad Ruback

8117 Preston Rd.

Suite 300

Dallas, TX 75225

James Bell

5301 Spring Valley Rd.

Suite 200

Dallas, TX 75254

RE: 05-13-01421-CV

Akbar Alesha, LLC v. Quik-Way Retail Associates II, Ltd.

Counsel:

This appeal has been abated since January 15, 2015 due to the filing of bankruptcy by 

appellant Akbar Alesha, LLC. Please notify the Court of the current status of the bankruptcy 

proceedings within TEN DAYS of the date of this letter. We appreciate your attention to this 

matter.

Sincerely,

/s/ Lisa Matz, Clerk of the Court

ltr:mrh
#### The People of the State of New York ex rel. Frank Lagano, Appellant, v William A. Lee, Respondent.

Submitted September 10, 2012;

decided October 30, 2012

On the Court’s own motion, appeal dismissed, without costs, upon the ground that the order appealed from does not finally determine the proceeding within the meaning of the Constitution. Motion for leave to appeal dismissed upon the ground that the order sought to be appealed from does not finally determine the proceeding within the meaning of the Constitution. Motion for poor person relief dismissed as academic.
Electronic File Format for Form BA-15 

Report of Stock Options and Other Payment

Column

Field

Length

Record

Position Data and Instructions

1 1 1 I = Initial; R = Replacement

2 4 2‐5 Year being reported (CCYY).3 4 6‐9 Four‐digit employer BA number assigned by the Railroad Retirement Board.

4 9 10‐18 Employee's social security account number.5 20 19‐38 First twenty (20) characters of the employee's surname. Spaces in such names as O Grady or D

6 15 39‐53 First fifteen (15) characters of the employee's first name.

7 1 54 Employee’s middle initial.8 1 55 Filler, leave blank9 10 56‐65 Medicare Wages and Tips First Quarter Amount ‐ 10 positions ($$$$$$$$¢¢), preceded by zer

10 10 66‐75 Medicare Wages and Tips Second Quarter Amount ‐10 positions ($$$$$$$$¢¢), preceded by z

11 10 76‐85 Medicare Wages and Tips Third Quarter Amount ‐ 10 positions ($$$$$$$$¢¢), preceded by ze

12 10 86‐95 Medicare Wages and Tips Fourth Quarter Amount ‐ 10 positions ($$$$$$$$¢¢), preceded by z

13 1 96 Filler, leave blank14 10 97‐106 RRTA Gross Compensation First Quarter Amount ‐ 10 positions ($$$$$$$$¢¢), preceded by ze

15 10 107‐116 RRTA Gross Compensation Second Quarter Amount ‐ 10 positions ($$$$$$$$¢¢), preceded by 

16 10 117‐126 RRTA Gross Compensation Third Quarter Amount ‐ 10 positions ($$$$$$$$¢¢), preceded by z

17 10 127‐136 RRTA Gross Compensation Fourth Quarter Amount ‐ 10 positions ($$$$$$$$¢¢), preceded by 

18 1 137 Filler, leave blank

19 10 138‐147 Non‐Qualified Stock Options First Quarter Amount ‐ 10 positions ($$$$$$$$¢¢), preceded by 

20 10 148‐157 Non‐Qualified Stock Options Second Quarter Amount ‐ 10 positions ($$$$$$$$¢¢), preceded 

21 10 158‐167 Non‐Qualified Stock Options Third Quarter Amount ‐ 10 positions ($$$$$$$$¢¢), preceded by 

22 10 168‐177 Non‐Qualified Stock Options Fourth Quarter Amount ‐ 10 positions ($$$$$$$$¢¢), preceded b

23 1 178 Filler, leave blank

24 10 179‐188 Ratification Payments First Quarter Amount ‐ 10 positions ($$$$$$$$¢¢), preceded by zero(s) 

25 10 189‐198 Ratification Payments Second Quarter Amount ‐ 10 positions ($$$$$$$$¢¢), preceded by zero

26 10 199‐208 Ratification Payments Third Quarter Amount ‐ 10 positions ($$$$$$$$¢¢), preceded by zero(s

27 10 209‐218 Ratification Payments Fourth Quarter Amount ‐ 10 positions ($$$$$$$$¢¢), preceded by zero

NOTE: If there are no earnings for the quarter, zero-fill.
@conference{1207236,
  author = {Anil Gurgen and Dagistan Sahin and James Whipple},
  title = {Quantifying Reactor Power Noise - A Case Study on NIST Research Reactor},
  year = {2023},
  month = {2023-05-26 04:05:00},
  publisher = {Proceedings of the 2023 30th International Conference on Nuclear Engineering, Kyoto, JP},
  url = {https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=936089},
  language = {en},
}
# Press Releases

- RRB Appoints Jebby Rasputnis as Deputy Director of Programs 
- RRB Appoints Jack Schreibman as Director of Administration 
- Tax Forms for Railroad Unemployment and Sickness Benefits Available Online 
- Q&A: Legal Partition and Railroad Retirement Employee Annuities 
- RRB Will Use Survey Results to Improve Disability Benefit Programs 
- Brandenburg Named Attorney-Advisor to RRB Management Member 
- RRB’s Field Service Recognized for Improved Employee Satisfaction 
- Sequestration Will Reduce Railroad Unemployment and Sickness Benefits Due to End of COVID-19 National Emergency 
- RRB Names Director of Policy and Systems 
- Q&A: Credit for Military Service under the Railroad Retirement Act
Exhibit 23.2

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Registration Statements (Form S-8 No. 333-105191) pertaining to the ThermoGenesis Corp. Amended 1998 Employee Equity Incentive Plan, (Form S-8 Nos. 333-28653 and 333-08661) pertaining to the ThermoGenesis Corp. Amended 1994 Stock Option Plan, (Form S-8 Nos. 333-46911 and 333-37228) pertaining to the ThermoGenesis Corp. 1998 Employee Equity Incentive Plan, (Form S-8 No. 333-82900) pertaining to the ThermoGenesis Corp. Amended 1998 Employee Equity Incentive Plan, 2002 Independent Directors Equity Incentive Plan, and Non-Qualified Independent Director Stock Option Agreement, and (Form S-3 Nos. 333-61118, 333-23097, 333-01479, 333-44151, 333-72035, 333-95143, 333-86312, 333-104671, and 333-114130) of ThermoGenesis Corp. and in the related Prospectuses of our report dated August 26, 2005, with respect to the financial statements and schedule of ThermoGenesis Corp.,ThermoGenesis Corp. management’s assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of ThermoGenesis Corp, included in the Annual Report (Form 10-K) for the year ended June 30, 2005.

 

/s/ ERNST & YOUNG LLP

Sacramento, California

September 6, 2005
http://www.shsmd.org/futurescan
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

In connection
with the Quarterly Report of LifeCare Holdings, Inc. (the Company) on Form 10-Q for the quarter ended June 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, G. Wayne
McAlister, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 220, that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial position and results of operations of the Company.
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------

Date: August 14, 2008



/s/ G. WAYNE McALISTERG. Wayne McAlisterChief Executive Officer
#### FORT WAYNE CORRUGATED PAPER CO. v. ANCHOR HOCKING GLASS CORPORATION, et al.

No. 385 Civil Action.

District Court, W. D. Pennsylvania.

Feb. 13, 1941.

See, also, D.C., 31 F.Supp. 403.

Patterson, Crawford, Arensberg & Dunn, of Pittsburgh, Pa., for plaintiff.

Elder W. Marshall, Jno. C. Bane, Jr., and Reed, Smith, Shaw & McClay, all of Pittsburgh, Pa., for defendants.

SCHOONMAKER, District Judge.

This is a suit involving, among other things, a claim for damages for the alleged failure of defendants to make purchases of shipping containers alleged to have been required by certain contracts between the parties. The original complaint stated this damage to be $250,000. By supplemental complaint filed on November 9, 1940, plaintiff fixed this claim at $450,000.

Defendants have now moved for a bill of particulars specifying the items which are intended to be comprised in the damage-claim of $450,000. This motion is predicated on Rule 12(e) of the Rules of Civil Procedure, 28 U.S.C.A. following section 723c, which permit a party to move “for a bill of particulars of any matter which is not averred with sufficient definiteness or particularity to enable him properly to prepare his responsive pleading or to prepare for trial.”

We are of the opinion that the complaint is sufficiently definite, and will deny the motion.

Defendants’ counsel have cited our opinion in Murphy v. E. I. DuPont De Nemours & Co., D.C., 26 F.Supp. 999, as supporting their motion. In this case we permitted an itemization of damages where there was a lump claim for damages for destruction of trees and growing trees, for injury to health, for inconvenience, depreciation in the value of real estate, a depreciation of the rental value of this real estate, and including also an exemplary damage-claim. That is not the situation of this case where we have merely a damage-claim for failure to purchase shipping containers alleged to *648have been required of defendants by contract between the parties.

Certainly this information is not necessary to enable the defendants to prepare a responsive answer, or to prepare for trial. If defendants desire information as to the facts plaintiff hopes to prove, they may be obtained by interrogatories under Rule 33.

An order may be submitted denying defendants’ motion for bill of particulars.
Exhibit 31.1

CERTIFICATION

I,

Shaheen Jivraj-Sangara

, certify that:

1.

I have reviewed this report for the fiscal quarter ended

June 30, 2006

 of Georgia Exploration Inc.

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statement, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;

4.

The small business issuers other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and have:

a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which the annual report is being prepared;

b)

evaluated the effectiveness of the small business issuers disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c)

disclosed in this report any change in the small business issuers internal control over financial reporting that occurred during the small business issuers most recent fiscal quarter (the small business issuers fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect the small business issuers internal control over financial reporting; and

5.

The small business issuers other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuers auditors and the audit committee of small business issuers board of directors (or persons performing the equivalent function):

a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuers ability to record, process, summarize and report financial information; and

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuers control over financial reporting.

Date: August 14, 2006

By:

/s/ Shaheen Jivraj-Sangara

Shaheen Jivraj-Sangara

President and Principal Financial Officer
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Defense

###### Office of the Secretary

# AGENCY:

DoD, Per Diem, Travel and Transportation Allowance Committee.

# ACTION:

Notice of Revised Non-Foreign Overseas Per Diem Rates.

# SUMMARY:

                        The Per Diem, Travel and Transportation Allowance Committee is publishing Civilian Personnel Per Diem Bulletin Number 264. This bulletin lists revisions in the per diem rates prescribed for U.S. Government employees for official travel in Alaska, Hawaii, Puerto Rico, the Northern Mariana Islands and Possessions of the United States. AEA changes announced in Bulletin Number 194 remain in effect. Bulletin Number 264 is being published in the                         **Federal Register**                         to assure that travelers are paid per diem at the most current rates.                    

# DATES:

*Effective Date:*                         July 1, 2009.                    

# SUPPLEMENTARY INFORMATION:

                    This document gives notice of revisions in per diem rates prescribed by the Per Diem Travel and Transportation Allowance Committee for non-foreign areas outside the continental United States. It supersedes Civilian Personnel Per Diem Bulletin Number 263. Distribution of Civilian Personnel Per Diem Bulletins by mail was discontinued. Per Diem Bulletins published periodically in the                     **Federal Register**                     now constitute the only notification of revisions in per diem rates to agencies and establishments outside the Department of Defense. For more information or questions about per diem rates, please contact your local travel office. The text of the Bulletin follows:                
      ( print page 30552)          ( print page 30553)          ( print page 30554)          ( print page 30555)          ( print page 30556)    
      ( print page 30557)    
June 10, 2009.

Patricia L. Toppings,

OSD Federal Register, Liaison Officer, Department of Defense.

BILLING CODE 5001-06-M

[FR Doc. E9-15116 Filed 6-25-09; 8:45 am]

BILLING CODE 5001-06-C
IN THE SUPREME COURT OF PENNSYLVANIA MIDDLE DISTRICT COMMONWEALTH OF PENNSYLVANIA, Respondent

v. TYRONE MILLER, Petitioner : : : : : : : : : : : No. 559 MAL 2014 Petition for Allowance of Appeal from the Order of the Superior Court

ORDER PER CURIAM AND NOW , this 16th day of December, 2014, the Petition for Allowance of Appeal is DENIED
.
EXHIBIT 23.2



CONSENT OF INDEPENDENT ACCOUNTANTS

We consent to the reference to our firm under the caption "Experts" and the incorporation by reference in the Registration Statements of Magic Lantern Group, Inc.on Form S-3 (Nos. 333-101974, 333-116147 and 119013) of our report relating to the financial statements of Magic Lantern Group, Inc. as of December 31, 2004, which appears in the Annual Report to Stockholders on Form 10-K for the year ended December 31, 2004.

/s/  Schwartz Levitsky Feldman LLP

SCHWARTZ LEVITSKY FELDMAN LLP



Chartered Accountants

Toronto, Ontario, Canada





April 26, 2005
**IMMUCELL CORPORATION**

**EXHIBIT 10.7**

**AMENDMENT TO EMPLOYMENT AGREEMENT**

IMMUCELL CORPORATION, a Delaware corporation (the “Company”), and JOSEPH H. CRABB, an individual residing inFalmouth, Maine (“Crabb”), hereby agree as follows as of this 26th day of March 2010. 

1.        This agreement supersedes and replaces in its entirety the Employment Agreement, dated as of April 29, 1999, as amended by the Employment Agreement, dated January 1, 2005, and theEmployment Agreement, dated as of July 28, 2005, each between the Company and Crabb. This agreement, together with the Confidential Information, Inventions and Noncompete Agreement, dated of even date herewith, between the Company and Crabb andany stock option agreements previously entered into between the Company and Crabb, constitute the parties’ entire understanding with respect to Crabb’s employment by the Company. 

2.        Crabb shall serve as Vice President and Chief Scientific Officer of the Company in an“at will” capacity on such terms as the Board of Directors of the Company may from time to time determine, subject to termination by the Board of Directors of the Company at any time, with or without cause. 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement, intending the same to take effect as a sealed instrument, as of thedate first above written.